Images List Premium Download Classic

Cancer

Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous ...
Universal Diagnostics, S.l.
November 30, 2017 - N°20170343567

Described herein are sets of metabolite and lipid (e. G., fatty acid) markers that can be used in the detection of early stage colorectal cancer and/or early development of adenomatous polyps. Presented herein are illustrative pathology-linked panels. In certain embodiments, the markers presented herein (or subsets thereof) are used as a panel for detecting either colorectal cancer or adenomatous ...
Methods and compositions for single chain variable region enox2 antibodies for cancer detection and diagnosis
Mor-nuco Enterprises, Inc.
November 30, 2017 - N°20170343555

Cancers of different cellular or tissue origins express different enox2 cancer isoforms or combinations of isoforms and shed these proteins into the circulation. Herein are disclosed methods both for cancer detection and diagnosis of particular origin, based on the patterns and molecular weights of the isoforms which allow the identification of the cell type and or tissue of origin of ...
Method of diagnosing and treating prostate cancer
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
November 30, 2017 - N°20170343551

A method of diagnosing a potentially lethal prostate cancer in a patient comprising measuring one of a level of sam pointed domain containing ets transcription factor (spdef) expression in the patient, a level of twist1 protein in the patient, and a level of matrix metalloproteinase 9 (mmp-9) expression in the patient, and diagnosing the patient with potentially lethal prostate cancer if ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Arteriosclerosis and cancer detection method using deoxyhypusine synthase gene as indicator
National University Corporation Chiba University
November 30, 2017 - N°20170343547

The present inventors have surprisingly found that a deoxyhypusine synthase (dhps) gene, which was previously reported to correlate with prostate cancer and cervical cancer, is highly responsive to arteriosclerosis or digestive system cancer, whereby the gene can be used as a desired marker for arteriosclerosis or digestive system cancer. The present invention has been accomplished on the basis of this ...
Device, system and method for cancer prognosis and uses thereof
Cedars-sinai Medical Center
November 30, 2017 - N°20170342506

Modules, devices, systems and methods for measuring or detecting cysteine and/or methionine metabolite levels in a sample from a subject are disclosed. Various embodiments of the present invention concern modules, devices, systems and methods for prognosing or diagnosing cancer, for example, prostate, colon, ovarian or breast cancer; predicting the risk or probability of cancer recurrence; and/or for predicting, ...
Early ovarian cancer detection diagnostic test based on mrna isoforms
The Regents Of The University Of California
November 30, 2017 - N°20170342504

A method to detect ovarian cancer is provided that employs probes and/or primers to detect certain rna isoform transcripts, as well as kits therefor.
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Biomarkers for breast cancer and methods of use thereof
Wisconsin Alumni Research Foundation
November 30, 2017 - N°20170342502

Described herein is the use of agouti signaling protein (asip), in addition to certain other melanocortin signaling network (msn) genes, as prognostic and predictive biomarkers for the progression of breast cancer. In particular, the novel biomarkers can be used to determine if a female breast cancer patient is at risk of progressing to metastatic disease and thus also be used ...
Use of gene expression profiling to predict survival in cancer patient
Bioventures, Llc
November 30, 2017 - N°20170342501

Gene expression profiling in multiple myeloma patients identifies genes that distinguish between patients with subsequent early death or long survival after treatment. Poor survival is linked to over-expression of genes such as aspm, opn3 and cks1b which are located in chromosome 1q. Given the frequent amplification of 1q in many cancers, it is possible that these genes can be ...
Genomic classifier that predicts response to multi-kinase inhibitor treatment introduction
Centre Léon-bérard
November 30, 2017 - N°20170342499

The method for predicting the anti-tumor response in a human or animal having a tumor to multiple kinase inhibitors, using any multiple kinase inhibitor, comprises selection of genes encoding for protein kinases targeted by the said tyrosine kinase inhibitor, for each one of these genes, providing at least one nucleic acid probe which hybridizes to said gene under stringent conditions, ...
Methods of using microrna-199a
Stemirna Therapeutics Co., Ltd.
November 30, 2017 - N°20170342421

Provided herein are methods of treating a cancer in an individual. A microrna-199a oligonucleotide or mimic that increases the expression of microrna-199a in the cancer cell is administered to the individual. Also provided is a method of inhibiting proliferation of a cancer cell and treating a cell associated with a cancer. The cell is contacted with the microrna-199...
Compositions and methods for treating pancreatic cancer
Autotelic Llc
November 30, 2017 - N°20170342419

Provided herein are composition for sensitizing tumors to anti-tumor therapies. The compositions include antisense oligonucleotides against tgfβ2, wherein the compositions sensitize tumors to anti-tumor therapies. Also provided herein are method for treating cancer using the compositions described herein.
Use of microrna precursors as drugs for inducing cd34-positive adult stem cell expansion
Autotelic Llc
November 30, 2017 - N°20170342418

This invention generally relates to a composition and its production method useful for developing drugs/vaccines and/or therapies against a variety of degenerative diseases in humans. Particularly, the present invention teaches the essential steps of production and purification processes necessary for producing small hairpin-like rna (shrna) compositions, such as microrna precursors (pre-mirna) and short interfering rnas (sirna), which are ...
Methods of using microrna-141
Stemirna Therapeutics Co., Ltd.
November 30, 2017 - N°20170342417

Provided herein are methods of treating a cancer in an individual. A microrna-141 oligonucleotide or mimic that increases the expression of microrna-141 in the cancer cell is administered to the individual. Also provided is a method of inhibiting proliferation of a cancer cell and treating a cell associated with a cancer. The cell is contacted with the microrna-141 oligonucleotide or ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Antibody binding to carbonic anhydrase and use thereof
Dinona
November 30, 2017 - N°20170342161

Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of ...
Humanized anti-cd70 binding agents and uses thereof
Seattle Genetics, Inc.
November 30, 2017 - N°20170342157

Disclosed are cd70 binding agents, such as humanized anti-cd70 antibodies and fragments and derivatives, that exert a cytotoxic, cytostatic or immunomodulatory on cd70 expressing cells, as well as pharmaceutical compositions and kits comprising the antibody, fragment or derivative. Also disclosed are methods for the treatment of cd70-expressing cancers and immunological disorders, comprising administering to a subject the cd70 binding ...
Fully human anti-cxc chemokine receptor 5 (cxcr5) antibodies
Sorrento Therapeutics, Inc.
November 30, 2017 - N°20170342156

There is disclosed compositions and methods relating to or derived from anti-cxcr5 antibodies. More specifically, there is disclosed fully human antibodies that bind cxcr5, cxcr5-binding fragments and derivatives of such antibodies, and cxcr5-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods ...
Hla-dr binding peptides and their uses
University Of Washington
November 30, 2017 - N°20170342126

The present invention provides hla-dr (mhc class ii) binding peptides derived from the ovarian/breast cancer associated antigens, human epidermal growth factor receptor 2 (her-2/neu), carcinoembryonic antigen (cea), insulin growth factor binding protein 2 (igfbp-2), and cyclin d1. The immunogenic peptides can be used in cancer vaccines.
Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer ...
Immatics Biotechnologies Gmbh
November 30, 2017 - N°20170342125

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Immunotherapy against erbb-3 receptor
Takis S.r.l.
November 30, 2017 - N°20170342123

The present invention describes methods and pharmaceutical compositions for the treatment of cancer in mammals, more particularly in human subjects. More specifically, the invention concerns anti-tumor vaccines based upon plasmid dna and/or genetic vectors carrying a codon-usage optimized sequence and coding for a mutant form of the erbb-3 receptor. Furthermore, the invention refers to monoclonal antibodies directed against the ...
Compounds and methods for the treatment of drug resistance in cancer cells against paclitaxel
Takis S.r.l.
November 30, 2017 - N°20170342086

The disclosure provides compounds and methods for treating cancer by inhibiting the formation of cancer cells resistant to paclitaxel by preventing the formation of gbp1:pim1 protein interaction during a chemotherapeutic treatment. These compounds and methods are able to treat cancer individually or in conjunction with paclitaxel.
Novel 1,3,5 -triazine based pi3k inhibitors as anticancer agents and a process for the preparation ...
Council Of Scientific And Industrial Research
November 30, 2017 - N°20170342049

The present invention describes heterocyclic compounds of general formula 1 and their method of preparation thereof. The present invention describes general formula 1 which inhibits phosphoinositide 3-kinase (pi3k) and can be used as the anticancer agents.
Loading